Peroxitech is a biotech start-up out of the University of Pennsylvania.  Our lead program is a breakthrough treatment for acute lung injury.  The most pressing indication for our lead candidate is COVID-19 induced acute lung injury.  In these patients, acute lung injury is the leading cause of death.  Our co-founders and scientists discovered a new pathway and a novel drug to treat and prevent acute lung injury.

Peroxitech LLC